Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive prelimi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback